Why the study?
Does a reperfusion strategy reduce hospital morbidity and mortality in patients aged ≥85 years with STEMI compared to conservative treatment?
Population
102 patients aged ≥85 years with ST-segment elevation myocardial infarction admitted to a coronary care…
Comparison
Reperfusion strategy vs Conservative treatment (n=35)
Design
Cohort
Follow-up
hospital stay
Authors
Loading...
Reperfusion was associated with lower mortality in very elderly STEMI patients; leaves open confirmation in randomized trials before changing practice.
Does a reperfusion strategy reduce hospital morbidity and mortality in patients aged ≥85 years with STEMI compared to conservative treatment?
In very elderly patients (≥85 years) with STEMI, reperfusion therapy is associated with significantly lower hospital mortality and morbidity compared to conservative management.
Renilla et al. (2012) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: